The inclusion in our network analysis of the AMPLITUDE-O and EMPEROR-P data have modified the conclusions of the most recent similar analysis [15] indicating that SGLT-2 inhibitors increased the risk of stroke as compared with GLP-1RA and that GLP-1RA are superior to DPP-4 inhibitors as for nonfatal MI
Raz I, Fonseca V, Kipnes M, Durrwell L, Hoekstra J, Boldrin M, et al
Can I skip GLP-1 medications on vacation
This highlights the importance of personalized healthcare, where the treatment plan can be tailored to an individuals needs
You can also schedule a call with our fitness professional to get personalized recommendations to help reach this goal based on your starting point
The study, which was titled Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned? and published in Endocrine Connections , encouraged the scientific community to further examine GLP-1 drugs and whether they increase the risks of certain cancers